iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench
30 Oct 2012

iCell Neurons derived from induced pluripotent stem cells (iPSCs) overcome existing models’ limitations in functionality, purity and reproducibility and offer a virtually unlimited supply of well-characterized cells for drug efficacy screening and safety testing. Importantly, using the iPSC technology to produce neurons enable more biologically relevant disease modeling, improved drug screening strategies, and forward movement toward personalized medicine.

Cellular Dynamics International



Show    per page
1 of 10 Page     1 2 3  ... Next 
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read
Applications of rheology in the waxes, creams and emulsions arena5 Sep 2014Read
Avoiding Bottlenecks When Validating Your Laboratory Instrument and Information Systems20 Aug 2014Read
A New Concept in Metabolic Studies: How Personalized 'Sportomics' Bridges Bench and Clinical Science24 Jul 2014Read
Process development and optimisation using ambr250™ for mammalian and microbial processes2 Jul 2014Read
Why does ice cream taste smooth or gritty? It depends on the rheology!30 Jun 2014Read